Dec. 17, 2024: -- As previously announced, we are
Post# of 152591

Feb. 24, 2025: -- Based on these survival observations, the Company has initiated two pre-clinical studies in mTNBC
LL / Trovdely testing started between Dec. 18th - Feb. 23rd
Results possible any day.

